According to Orchard Therapeutics 's latest financial reports the company's total assets are ยฃ0.14 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | ยฃ0.18 B | -24.24% |
2021-12-31 | ยฃ0.23 B | 15.89% |
2020-12-31 | ยฃ0.20 B | -32.31% |
2019-12-31 | ยฃ0.30 B | 5.59% |
2018-12-31 | ยฃ0.28 B | 300.57% |
2017-12-31 | ยฃ71.98 M | 1973.97% |
2016-12-31 | ยฃ3.47 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | ยฃ0.91 B | 517.41% | Jersey |
![]() Novavax NVAX | ยฃ0.94 B | 539.25% | ๐บ๐ธ USA |
![]() Organovo ONVO | ยฃ10.73 M | -92.76% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | ยฃ0.14 B | 0.00% | ๐ฌ๐ง UK |